Updated:
Chiratae Ventures
Chiratae Ventures advises India-focused technology venture capital funds. The firm targets seed and early-stage companies in consumer tech, software, fintech,...
Chiratae Ventures
Chiratae Ventures advises India-focused technology venture capital funds. The firm targets seed and early-stage companies in consumer tech, software, fintech, healthtech and deep tech. It commits to Seed, Series A and Series B rounds across Asia. Confirmed positions include eight unicorns reached from an overall portfolio of 136 investments. Capital flows through direct startup checks and follow-on rounds rather than fund-of-funds structures. The firm lists no additional offices and reports no recent operational events in the last 24 months. No philanthropic vehicles or club memberships appear in available records. Chiratae Ventures operates without a disclosed single-family principal or succession plan, leaving investment decisions inside the asset manager structure itself.
General information
Firm type
Venture Capital
Year founded
—
AUM
Undisclosed
Location
Region
Asia
Country
India
City
Bengaluru
Corporate office
Bengaluru, India
Sector focus
Frequently asked questions
Who runs investment decisions at Chiratae Ventures?
No named principals or CIO appear in the provided sources.
What investment stages does Chiratae Ventures target?
The firm targets Seed, Series A and Series B rounds.
Does Chiratae Ventures participate in fund commitments or only direct deals?
It makes direct investments in startups through its Sonic and Spotlight programs.
Which sectors does Chiratae Ventures focus on?
Sectors include AI/ML, consumer tech, enterprise software, fintech, healthtech and space tech.
Where does Chiratae Ventures invest geographically?
All activity centers on Asia with headquarters in Bengaluru, India.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: